The Centers for Medicare and Medicaid Services has published several policies on biosimilars reimbursement.
A recent study discovered a biomarker in chronic inflammatory demyelinating polyneuropathy patients that explains why they don’t respond to intravenous immune globulin therapy.
The U.S. Food and Drug Administration has approved Baxalta’s Adynovate for use in hemophilia A patients aged 12 years and older.
In response to concerns by providers about the ICD-9 to ICD-10 coding system, the Centers for Medicare and Medicaid Services says it will reimburse for incorrectly coded claims for one year past the Oct. 1, 2015, deadline.
Results of a Phase III study show that BAX 111, a highly purified recombinant von Willebrand factor analog manufactured by Baxalta, appeared safe and effective for treatment of bleeding episodes in patients with severe von Willebrand’s disease.
The Centers for Medicare and Medicaid Services has created an interactive online dashboard to allow the public and policymakers to explore the financial burden that high-expense drugs place on the Medicare program and the nation’s seniors.
University of Cincinnati researchers have discovered that a human cancer-causing gene, called DEK, can be detected in the plasma of head and neck cancer patients.
A new form of hybridized sound waves developed by Australian researchers may allow drugs and vaccines to be delivered to the body through a nebulizer in a fine mist inhaled into the lungs.
The U.S. Food and Drug Administration issued a new guidance recommending the deferral of individuals from donating blood if they have been to areas with active Zika virus transmission, potentially have been exposed to the virus or have had a confirmed Zika virus infection.
The U.S. Food and Drug Administration has approved Fluad (Seqirus), an influenza vaccine that contains the adjuvant MF59.
The U.S. Department of Health and Human Services (HHS) has announced additional funding under the Affordable Care Act (ACA) and other programs. Under the ACA, nearly $500 million is being awarded to health centers nationwide to provide primary care services to those who need them most.
